ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $95,095,000 | +799.2% | 2,052,554 | +373.2% | 0.06% | +742.9% |
| Q1 2019 | $10,575,000 | +17.5% | 433,749 | -31.3% | 0.01% | 0.0% |
| Q4 2018 | $8,997,000 | -13.3% | 631,349 | -7.5% | 0.01% | 0.0% |
| Q3 2018 | $10,378,000 | +42.9% | 682,749 | +57.8% | 0.01% | +40.0% |
| Q2 2018 | $7,262,000 | +3.1% | 432,749 | +0.2% | 0.01% | 0.0% |
| Q1 2018 | $7,047,000 | +52.2% | 431,809 | +19.3% | 0.01% | +66.7% |
| Q4 2017 | $4,631,000 | +46.6% | 361,829 | +40.9% | 0.00% | +50.0% |
| Q3 2017 | $3,159,000 | +46.9% | 256,829 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,150,000 | -26.2% | 256,829 | -21.2% | 0.00% | 0.0% |
| Q1 2017 | $2,912,000 | +46.6% | 325,779 | +44.2% | 0.00% | 0.0% |
| Q4 2016 | $1,986,000 | +48.3% | 225,929 | +13.9% | 0.00% | +100.0% |
| Q3 2016 | $1,339,000 | +89.7% | 198,329 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $706,000 | +20.7% | 198,329 | 0.0% | 0.00% | – |
| Q1 2016 | $585,000 | -35.4% | 198,329 | -7.5% | 0.00% | -100.0% |
| Q4 2015 | $905,000 | -7.5% | 214,429 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $978,000 | -36.8% | 214,429 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,548,000 | +5.7% | 214,719 | +8.1% | 0.00% | 0.0% |
| Q1 2015 | $1,464,000 | +52.0% | 198,619 | -2.4% | 0.00% | 0.0% |
| Q4 2014 | $963,000 | +32.5% | 203,519 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $727,000 | -22.7% | 203,519 | -1.2% | 0.00% | 0.0% |
| Q2 2014 | $940,000 | -3.0% | 206,093 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $969,000 | -6.2% | 206,093 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,033,000 | -19.4% | 206,093 | -0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,282,000 | +36.1% | 206,131 | -0.6% | 0.00% | 0.0% |
| Q2 2013 | $942,000 | – | 207,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |